Cite
Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo.
MLA
Slivicki, Richard A., et al. “Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo.” PLoS ONE, vol. 11, no. 1, Jan. 2016, pp. 1–15. EBSCOhost, https://doi.org/10.1371/journal.pone.0147620.
APA
Slivicki, R. A., Ali, Y. O., Lu, H.-C., & Hohmann, A. G. (2016). Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo. PLoS ONE, 11(1), 1–15. https://doi.org/10.1371/journal.pone.0147620
Chicago
Slivicki, Richard A., Yousuf O. Ali, Hui-Chen Lu, and Andrea G. Hohmann. 2016. “Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo.” PLoS ONE 11 (1): 1–15. doi:10.1371/journal.pone.0147620.